Social & Recreational Activities
8th US - Japan Symposium on Drug Delivery Systems
Sunday, December 18, 2005
| 3:00 – 5:30 p.m. | Registration | Ocean Lanai Terrace |
| 5:45 – 6.55 p.m. | Welcome Reception | Lanai Kauai/Pool Deck |
| 7:00 p.m. | Evening session | Haleakala Ballroom |
|
Introduction: Discussion Leader: 9:00 – 9:30 p.m. |
Robert Langer and Yasuhiko Tabata Rodney Pearlman Coffee Break |
| Speakers |
Michael Cima |
Monday, December 19, 2005
| 7:00 – 8:00 a.m. | Registration | Ocean Lanai Terrace |
| 8:30 a.m. | Morning Session | Haleakala Ballroom |
|
Discussion Leader: 10:45 – 11:15 a.m. |
Allan Hoffman
Coffee Break |
| Speakers |
Francis
Szoka Professor of Biopharmaceutical Sciences, University of California, San Francisco Targeting tumors with proteins, polymers and liposomes Takashi Miyata Professor, Kansai University Smart gels that respond to biomolecules Nicholas Peppas Fletcher S. Pratt Chair of Chemical Engineering, Biomedical Engineering and Pharmaceuticals, University of Texas - Austin Intelligent therapeutics and bionanotechnology Hideyuki Okano Professor, Keio University School of Medicine Neural stem cells and CNS-repair Henry Brem Chair, Dept of Neurosurgery, Johns Hopkins University School of Medicine Drug delivery for brain tumor therapy |
Afternoon Unscheduled
| 7:30 p.m. | Evening Session | Haleakala Ballroom |
|
Discussion Leader: 8:50 p.m. |
Naofumi
Hashimoto Refreshment Break |
| Speakers | John Patton Founder and CSO, Nektar Therapeutics Applicability of inhalation delivery to medicine Jeff Hrkach Senior Director of Drug Delivery, Momenta Pharmaceuticals, Inc. Non-invasive glycan-mediated drug delivery David Edwards Co-Founder, Pulmatrix, Inc. A new approach to treating the flu and other infectious airborne diseases Stephen Farr SVP and CSO, Aradigm Corp Integrating needle-free injection into mainstream drug delivery science |
Tuesday, December 20, 2005
| 8:30 a.m. | Morning Session | Haleakala Ballroom |
|
Discussion Leader: 10:30 - 11:00 a.m. |
Ryoji
Konishi Coffee Break |
| Speakers | Masashi Komeda Professor and Chair, Kyoto University Hospital Developing new treatment of heart disease by combining DDS with cardiac surgery Howard Rosen VP., Commercial Strategy, Gilead Sciences, Inc. Anti-infective therapies: Past, present and future Kazuhiro Sako Senior Director, Product Value Maximization, Astellas Pharm, Inc. Novel oral controlled release technologies for product value maximization Sung Wan Kim Distinguished Professor, University of Utah Gene delivery for the treatment of diabetes Rie Igarashi Professor, St. Marianna University School of Medicine Nano-egg and nano-cube, new technology for transdermal drug delivery systems |
Afternoon Unscheduled
| 7:30 – 9:30 p.m. | Evening Session | Haleakala Ballroom |
|
Oral Presentation of
Posters: Discussion Leader: 8:30 p.m. |
Selected
from Poster Session #1
Michael Sefton |
Wednesday, December 21, 2005
| 8:30 a.m. | Morning Session | Haleakala Ballroom |
|
Discussion Leader: 10:00 - 10:30 a.m. |
V. Prasad Shastri Coffee Break |
| Speakers | Gary Cleary President and CTO, Corium International, Inc. Advances in Drug Delivery Using Mechanical Microporation John Siebert Chairman and CEO, Cydex, Inc. Can enabling technology be a stairway to heaven business model? Gerald Bernstein VP, Medical Affairs, Director, Generex Biotechnology Corp Buccal delivery of insulin: A simple solution to a complex problem Kazunari Taira Professor, University of Tokyo It's a small RNA world that makes a big revolution in the biomedical field Michael Goldberg President and CEO, Emisphere Technologies, Inc. Oral macromolecule delivery: Review of the large and expanding clinical database |
Afternoon Unscheduled
| 7:30 p.m. | Evening Session | Haleakala Ballroom |
|
Discussion Leader: 8:50 p.m. |
Yasuhiko Tabata Refreshment Break |
| Speakers | Larry Brown
CTO, Epic Therapeutics - a wholly owned subsidiary of Baxter Healthcare Corporation PROMAXX monoclonal antibody, nucleic acid and protein microspheres Hideyoshi Harashima Professor, Hokkaido University Multifunctional envelope type nano-device for non-viral gene delivery: Concept and application of programmed packaging Mark Staples Vice President of Rsch & Dev, MicroCHIPS, Inc. Intelligent implantable devices: Solutions for drug delivery and biosensing Min Young Lee Vice President, Sam Yang Corporation Genexol-PM, a polymeric micelle-based formulation of paclitaxel, phase II studies with breast, lung, and pancreas cancer |
Thursday, December 22, 2003
| 8:30 a.m. | Morning Session | Haleakala Ballroom |
|
Discussion Leader: 10:30 - 11:00 a.m. |
Daniel S. Kohane Coffee Break |
| Speakers | Shigeru Kawakami Professor, Kyoto University Mannosylated cationic liposomes for DNA vaccine therapy Howard Bernstein Sr. Vice President Research & Development, Acusphere, Inc. Applications of porous microparticles for intravenous drug delivery Hiroshi Kikuchi Group Manager, R&D Division, Daiichi Pharmaceutical Co, Ltd New revolution in drug delivery systems: Liposome technology for siRNA delivery Thomas Schluep CSO, Insert Therapeutics, Inc. Cyclodextrin-based polymers for delivery of a broad range of therapeutics Shunji Nagahara Team Manager, Formulation Research Labs, Sumitomo Pharmaceuticals Co., Ltd Atelcollagen-Mediated Delivery Technology for Nucleic Acid Medicines |
Afternoon Unscheduled
| 7:30 – 9:30 p.m. | Evening Session | Haleakala Ballroom |
|
Oral Presentation of
Posters: Discussion Leader: 8:30 p.m. |
Selected
from Poster Session #2
Alexander Klibanov |
ADJOURN AT
APPROXIMATELY 10:00 P.M.
Thank You for Participating.
We Hope to See you at the 9th Symposium in 2007.
If you do not have Adobe
Acrobat Reader, you can download it for free.
* Speaker is listed first when multiple names appear above.
Copyright © 2002 Massachusetts Institute of Technology
Comments and questions to langerlab-www@mit.edu